SAN MATEO, Calif., May 16, 2024 (GLOBE NEWSWIRE) Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional
W Africa gets 3 Oxford scholarship slots from Rhodes Trust – The Sun Nigeria sunnewsonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sunnewsonline.com Daily Mail and Mail on Sunday newspapers.